ID: ALA2418967

Max Phase: Preclinical

Molecular Formula: C15H16N4OS

Molecular Weight: 300.39

Molecule Type: Small molecule

Representations

Canonical SMILES:  NC(S)(/C=C/c1ccccc1)NNC(=O)c1ccncc1

Standard InChI:  InChI=1S/C15H16N4OS/c16-15(21,9-6-12-4-2-1-3-5-12)19-18-14(20)13-7-10-17-11-8-13/h1-11,19,21H,16H2,(H,18,20)/b9-6+

Standard InChI Key:  XOTFACJDPHNNJM-RMKNXTFCSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 300.39

Molecular Weight (Monoisotopic): 300.1045

AlogP: 1.57

#Rotatable Bonds: 5

Polar Surface Area: 80.04

Molecular Species: NEUTRAL

HBA: 5

HBD: 4

#RO5 Violations: 0

HBA (Lipinski): 5

HBD (Lipinski): 4

#RO5 Violations (Lipinski): 0

CX Acidic pKa: 8.43

CX Basic pKa: 5.09

CX LogP: 2.06

CX LogD: 2.02

Aromatic Rings: 2

Heavy Atoms: 21

QED Weighted: 0.38

Np Likeness Score: -0.60

References

1. Matei L, Bleotu C, Baciu I, Draghici C, Ionita P, Paun A, Chifiriuc MC, Sbarcea A, Zarafu I..  (2013)  Synthesis and bioevaluation of some new isoniazid derivatives.,  21  (17): [PMID:23823011] [10.1016/j.bmc.2013.06.013]

Source

Source(1):

• Scientific Literature